Sidley Healthcare Conference
Biotech

GSK aiming to ‘balance West and East’ since Hansoh deal success

GSK has been operating a strategy of “balancing the West and the East” since the Big Pharma’s collaboration with Hansoh, according to an executive.
James Waldron Sep 23, 2026 5:00am
als

Beyond clinical endpoints: Rethinking ALS drug development through disease biology

Brought to you by Neurizon Therapeutics
Make a delay and accumulation of outstanding tasks Full stop

Immunovant ends cutaneous lupus program after phase 2 flop

Sep 23, 2026 8:59am
Roche

Roche’s ph. 3 win tees up blockbuster fight with Novartis

Sep 23, 2026 3:50am
Funding

Enveda reaps $311M round to help become ‘household name’

Sep 23, 2026 9:47am
Flagship Pioneering office

Trump's Department of War bets $47M for emerging threat research

Sep 23, 2026 9:35am
More News

Boehringer adds $250M to Variant pact via cardio expansion

Sep 23, 2026 8:55am

Novartis secures new radioligand in $900M deal

Sep 22, 2026 1:22pm

Celldex monoclonal antibody rebounds with pair of phase 3 wins

Sep 22, 2026 10:30am

Amgen fusion protein eases Sjögren's severity in ph. 3 win

Sep 22, 2026 10:20am